Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion

被引:568
|
作者
Bengsch, Bertram [1 ,2 ]
Johnson, Andy L. [1 ,2 ]
Kurachi, Makoto [1 ,2 ]
Odorizzi, Pamela M. [1 ,2 ]
Pauken, Kristen E. [1 ,2 ]
Attanasio, John [1 ,2 ]
Stelekati, Erietta [1 ,2 ]
McLane, Laura M. [1 ,2 ]
Paley, Michael A. [1 ,2 ]
Delgoffe, Greg M. [3 ]
Wherry, E. John [1 ,2 ]
机构
[1] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Pittsburgh, Dept Immunol, Tumor Microenvironm Ctr, Inst Canc, Pittsburgh, PA 15232 USA
关键词
CHRONIC VIRAL-INFECTION; DISTINCT MECHANISMS; EFFECTOR FUNCTION; IMMUNE-RESPONSES; MEMORY; CHECKPOINT; DIFFERENTIATION; ACTIVATION; GLYCOLYSIS; EXPRESSION;
D O I
10.1016/j.immuni.2016.07.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dynamic reprogramming of metabolism is essential for T cell effector function and memory formation. However, the regulation of metabolism in exhausted CD8(+) T (Tex) cells is poorly understood. We found that during the first week of chronic lymphocytic choriomeningitis virus (LCMV) infection, before severe dysfunction develops, virus-specific CD8(+) T cells were already unable to match the bioenergetics of effector T cells generated during acute infection. Suppression of T cell bioenergetics involved restricted glucose uptake and use, despite persisting mechanistic target of rapamycin (mTOR) signaling and upregulation of many anabolic pathways. PD-1 regulated early glycolytic and mitochondrial alterations and repressed transcriptional coactivator PGC-1 alpha. Improving bioenergetics by overexpression of PGC-1 alpha enhanced function in developing Tex cells. Therapeutic reinvigoration by anti-PD-L1 reprogrammed metabolism in a subset of Tex cells. These data highlight a key metabolic control event early in exhaustion and suggest that manipulating glycolytic and mitochondrial metabolism might enhance checkpoint blockade outcomes.
引用
收藏
页码:358 / 373
页数:16
相关论文
共 50 条
  • [41] PD-1:PD-L inhibitory pathway affects both CD4+and CD8+ T cells and is overcome by IL-2
    Carter, LL
    Fouser, LA
    Jussif, J
    Fitz, L
    Deng, B
    Wood, CR
    Collins, M
    Honjo, T
    Freeman, GJ
    Carreno, BM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (03) : 634 - 643
  • [42] PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis
    Ping, Yu
    Shan, Jiqi
    Qin, Haiming
    Li, Feng
    Qu, Jiao
    Guo, Ru
    Han, Dong
    Jing, Wei
    Liu, Yaqing
    Liu, Jinyan
    Liu, Zhangnan
    Li, Jieyao
    Yue, Dongli
    Wang, Feng
    Wang, Liping
    Zhang, Bin
    Huang, Bo
    Zhang, Yi
    IMMUNITY, 2024, 57 (09)
  • [43] PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
    Fourcade, Julien
    Kudela, Pavol
    Sun, Zhaojun
    Shen, Hongmei
    Land, Stephanie R.
    Lenzner, Diana
    Guillaume, Philippe
    Luescher, Immanuel F.
    Sander, Cindy
    Ferrone, Soldano
    Kirkwood, John M.
    Zarour, Hassane M.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (09): : 5240 - 5249
  • [44] Formate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade
    Rowe, Jared H.
    Elia, Ilaria
    Shahid, Osmaan
    Gaudiano, Emily F.
    Sifnugel, Natalia E.
    Johnson, Sheila
    Reynolds, Amy G.
    Fung, Megan E.
    Joshi, Shakchhi
    LaFleur, Martin W.
    Park, Joon Seok
    Pauken, Kristen E.
    Rabinowitz, Joshua D.
    Freeman, Gordon J.
    Haigis, Marcia C.
    Sharpe, Arlene H.
    CANCER DISCOVERY, 2023, 13 (12) : 2566 - 2583
  • [45] PD-1 regulates size, function and duration of a vaccine-induced CD8+ T cell response
    Kuhlmann, K.
    Tartz, S.
    Mittruecker, H. W.
    Jacobs, T.
    IMMUNOLOGY, 2012, 137 : 23 - 23
  • [46] PD-1 inhibitors dependent CD8+ T cells inhibit mouse colon cancer cell metastasis
    Gao, Chang E.
    Zhang, Ming
    Song, Qian
    Dong, Jian
    ONCOTARGETS AND THERAPY, 2019, 12 : 6961 - 6971
  • [47] Harnessing CD8+ T-cell exhaustion to treat type 1 diabetes
    Kwong, Chun-Ting J.
    Selck, Claudia
    Tahija, Krisna
    McAnaney, Lachlan J.
    Le, Dan, V
    Kay, Thomas W. H.
    Thomas, Helen E.
    Krishnamurthy, Balasubramanian
    IMMUNOLOGY AND CELL BIOLOGY, 2021, 99 (05): : 486 - 495
  • [48] Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors
    Mishra, Ameet K.
    Kadoishi, Tanya
    Wang, Xiaoguang
    Driver, Emily
    Chen, Zhangguo
    Wang, Xiao-Jing
    Wang, Jing H.
    ONCOTARGET, 2016, 7 (49) : 81341 - 81356
  • [49] PD-1 receptor as chemotherapeutic agent for CD8 T cell recovery in HIV/AIDS
    Husain, Sajid
    Rao, Amara Rama
    INDIAN JOURNAL OF VIROLOGY, 2009, 20 (01): : 33 - 33
  • [50] Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells
    Elrefaei, Mohamed
    Baker, Chris A. R.
    Jones, Norman G.
    Bangsberg, David R.
    Cao, Huyen
    JOURNAL OF IMMUNOLOGY, 2008, 180 (11): : 7757 - 7763